虫草素
封锁
肿瘤微环境
癌症研究
结直肠癌
医学
癌症
化学
内科学
肿瘤细胞
受体
生物化学
作者
Chen Feng,Rongzhang Chen,Xinran Gao,Weiwei Fang,Shaoxian Wu,Lujun Chen,Xiao Wei Zheng,Xin‐Ying Ji,Maoling Yuan,Yuanyuan Fu,Hanjie Ying,Tao Shen,Dawei Zhu,Jingting Jiang
标识
DOI:10.1016/j.ejphar.2024.177089
摘要
BACKGROUND: PD-L1 blockade has been found to be effective in treating multiple malignancies. Combined therapy is proposed to provide better therapeutic effects. Cordycepin, a prominent bioactive compound found in cordyceps, can inhibit the development of various cancers. PURPOSE: This study aimed to determine the efficacy of combined anti-PD-L1 antibody and cordycepin in tumor treatment. METHODS: A single-cell RNA sequencing was used to analyze the mechanism of combined treatment. RESULTS: T cells. Furthermore, cordycepin promoted the reprogramming of type-II macrophages into type-I macrophages, a process confirmed through flow cytometry analysis of the underlying mechanism. CONCLUSION: Our findings demonstrate that the combination of anti-PD-L1 and cordycepin effectively suppressed tumor growth by regulating the proportion of T cells and reprograming type-II macrophages.
科研通智能强力驱动
Strongly Powered by AbleSci AI